Literature DB >> 27042840

Assessment of tumoral plasma cells in apheresis products for autologous stem cell transplantation in multiple myeloma.

S Wuillème1, A Lok2, N Robillard1, P Dupuis3, V Stocco3, H Migné1, A Dusquesne3, C Touzeau2, M Tiab4, M C Béné1, P Moreau2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27042840     DOI： 10.1038/bmt.2016.74

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  12 in total

1.  Promising therapies in multiple myeloma.

Authors:  Giada Bianchi; Paul G Richardson; Kenneth C Anderson
Journal:  Blood       Date:  2015-06-01       Impact factor: 22.113

Review 2.  Frontline therapy of multiple myeloma.

Authors:  Philippe Moreau; Michel Attal; Thierry Facon
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

3.  Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.

Authors:  R M Lemoli; M Cavo; A Fortuna
Journal:  J Hematother       Date:  1996-08

4.  High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma.

Authors:  Bruno Paiva; Norma C Gutiérrez; Laura Rosiñol; María-Belén Vídriales; María-Ángeles Montalbán; Joaquín Martínez-López; María-Victoria Mateos; María-Teresa Cibeira; Lourdes Cordón; Albert Oriol; María-José Terol; María-Asunción Echeveste; Raquel de Paz; Felipe de Arriba; Luis Palomera; Javier de la Rubia; Joaquín Díaz-Mediavilla; Anna Sureda; Ana Gorosquieta; Adrian Alegre; Alejandro Martin; Miguel T Hernández; Juan-José Lahuerta; Joan Bladé; Jesús F San Miguel
Journal:  Blood       Date:  2011-11-29       Impact factor: 22.113

5.  A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.

Authors:  M Attal; J L Harousseau; A M Stoppa; J J Sotto; J G Fuzibet; J F Rossi; P Casassus; H Maisonneuve; T Facon; N Ifrah; C Payen; R Bataille
Journal:  N Engl J Med       Date:  1996-07-11       Impact factor: 91.245

6.  High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients.

Authors:  J P Fermand; S Chevret; P Ravaud; M Divine; V Leblond; F Dreyfus; X Mariette; J C Brouet
Journal:  Blood       Date:  1993-10-01       Impact factor: 22.113

7.  Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests.

Authors:  J M Henry; P J Sykes; M J Brisco; L B To; C A Juttner; A A Morley
Journal:  Br J Haematol       Date:  1996-03       Impact factor: 6.998

8.  Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy.

Authors:  X Mariette; J P Fermand; J C Brouet
Journal:  Bone Marrow Transplant       Date:  1994-07       Impact factor: 5.483

9.  A single-tube multiparameter seven-colour flow cytometry strategy for the detection of malignant plasma cells in multiple myeloma.

Authors:  N Robillard; M C Béné; P Moreau; S Wuillème
Journal:  Blood Cancer J       Date:  2013-08-16       Impact factor: 11.037

10.  Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction.

Authors:  Andy C Rawstron; Walter M Gregory; Ruth M de Tute; Faith E Davies; Sue E Bell; Mark T Drayson; Gordon Cook; Graham H Jackson; Gareth J Morgan; J Anthony Child; Roger G Owen
Journal:  Blood       Date:  2015-02-02       Impact factor: 22.113
View more
  6 in total

1.  Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple Myeloma.

Authors:  Susan Bal; Heather J Landau; Gunjan L Shah; Michael Scordo; Parastoo Dahi; Oscar B Lahoud; Hani Hassoun; Malin Hultcrantz; Neha Korde; Nikoletta Lendvai; Alexander M Lesokhin; Sham Mailankody; Urvi A Shah; Eric Smith; Sean M Devlin; Scott Avecilla; Ahmet Dogan; Mikhail Roshal; Ola Landgren; Sergio A Giralt; David J Chung
Journal:  Biol Blood Marrow Transplant       Date:  2020-05-19       Impact factor: 5.742

Review 2.  Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation.

Authors:  Hiroyuki Takamatsu
Journal:  J Clin Med       Date:  2017-09-25       Impact factor: 4.241

3.  Timing the initiation of multiple myeloma.

Authors:  Even H Rustad; Venkata Yellapantula; Daniel Leongamornlert; Niccolò Bolli; Guy Ledergor; Ferran Nadeu; Nicos Angelopoulos; Kevin J Dawson; Thomas J Mitchell; Robert J Osborne; Bachisio Ziccheddu; Cristiana Carniti; Vittorio Montefusco; Paolo Corradini; Kenneth C Anderson; Philippe Moreau; Elli Papaemmanuil; Ludmil B Alexandrov; Xose S Puente; Elias Campo; Reiner Siebert; Herve Avet-Loiseau; Ola Landgren; Nikhil Munshi; Peter J Campbell; Francesco Maura
Journal:  Nat Commun       Date:  2020-04-21       Impact factor: 14.919

4.  Ten Color Multiparameter Flow Cytometry in Bone Marrow and Apheresis Products for Assessment and Outcome Prediction in Multiple Myeloma Patients.

Authors:  Veronika Riebl; Sandra Maria Dold; Dagmar Wider; Marie Follo; Gabriele Ihorst; Johannes M Waldschmidt; Johannes Jung; Michael Rassner; Christine Greil; Ralph Wäsch; Monika Engelhardt
Journal:  Front Oncol       Date:  2021-08-13       Impact factor: 6.244

Review 5.  Is Quantification of Measurable Clonal Plasma Cells in Stem Cell Grafts (gMRD) Clinically Meaningful?

Authors:  Guldane Cengiz Seval; Meral Beksac
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244

6.  Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.

Authors:  Tarek H Mouhieddine; Adam S Sperling; Robert Redd; Jihye Park; Matthew Leventhal; Christopher J Gibson; Salomon Manier; Amin H Nassar; Marzia Capelletti; Daisy Huynh; Mark Bustoros; Romanos Sklavenitis-Pistofidis; Sabrin Tahri; Kalvis Hornburg; Henry Dumke; Muhieddine M Itani; Cody J Boehner; Chia-Jen Liu; Saud H AlDubayan; Brendan Reardon; Eliezer M Van Allen; Jonathan J Keats; Chip Stewart; Shaadi Mehr; Daniel Auclair; Robert L Schlossman; Nikhil C Munshi; Kenneth C Anderson; David P Steensma; Jacob P Laubach; Paul G Richardson; Jerome Ritz; Benjamin L Ebert; Robert J Soiffer; Lorenzo Trippa; Gad Getz; Donna S Neuberg; Irene M Ghobrial
Journal:  Nat Commun       Date:  2020-06-12       Impact factor: 14.919
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.